Dihydronaphthalene compounds
    3.
    发明授权
    Dihydronaphthalene compounds 失效
    二氢萘化合物

    公开(公告)号:US06559157B2

    公开(公告)日:2003-05-06

    申请号:US09866179

    申请日:2001-05-25

    IPC分类号: A61K314409

    摘要: Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.

    摘要翻译: 二氢萘化合物具有优异的17α-羟化酶/ C17-20-裂解酶抑制活性,血栓素A2合成抑制活性和芳香酶抑制活性,因此可用作各种男性性激素和雌性激素依赖性的预防和/或治疗剂 诸如前列腺癌,前列腺肥大,男性化,乳腺癌,乳腺病,子宫癌,子宫内膜异位症和卵巢癌以及心肌梗塞,心绞痛和支气管哮喘的疾病。